CD274 and neoplasm: ACY-241 also reduced PD-L1 expression on Tregs and PD-1 expression on CD3+ T cells, upregulated CD80/86 and MHC molecules (class I and II) on both tumor and DCs and upregulated costimulatory and activation molecules on antigen-specific CTLs [178].